Surgery – Diagnostic testing – Respiratory
Patent
1999-04-23
2000-08-22
O'Connor, Cary
Surgery
Diagnostic testing
Respiratory
600532, A61B 508
Patent
active
061064807
DESCRIPTION:
BRIEF SUMMARY
The invention relates to an arrangement for the determination of the effective pulmonary blood flow according to the generic part of claim 1.
From the paper Steinhart, C. M., Burch, K. D., Bruno, S., Parker, D. H.: Noninvasive determination of effective (nonshunted) pulmonary blood flow in normal and injured lungs, Crit. Care Med., 1989, Vol. 17, No. 4, pp. 349-353 the Multiple-Inert-Gas method with rebreathing of helium, acetylene and carbon monoxide in oxygen and nitrogen from a respiratory bag is known. A disadvantage of this measurement is the relatively great effort to prepare the gas mixtures for rebreathing, the demand for special measuring instruments that can measure the concentrations of gases in the breathed air or the breathing flow, respectively, and the necessity of a person to connect the respiratory bag to the patient and maintain it. For those reasons the measurement of the effective pulmonary blood flow can only be executed by specialists and is for research purposes in almost all cases.
Further, from the paper by Inman, M. D., Hughson, R. L., and Jones, N. L.: Comparison of cardiac output during exercise by single-breath and CO.sub.2 rebreathing methods, J. Appl. Physiol., Vol. 58, pp. 1372-1377, 1985, the total CO.sub.2 rebreathing method and the so-called single-breath method are known. Disadvantages of these methods are distinct increases of CO.sub.2 pressure in the arterial blood, as the CO.sub.2 elimination is interrupted, and the impeding of the respiration. Other disadvantages are those of the Multiple-Inert-Gas method, namely the preparation of gas mixtures for rebreathing having certain CO.sub.2 concentrations, the demand for special measuring instruments that can measure the concentrations of gases in the breathed air or the breathing flow, respectively, and the necessity of a person to connect the respiratory bag to the patient and maintain it.
Another method known is a partial CO.sub.2 rebreathing method (according to Gedeon, A., Forstund, L., Hedenstierna, G. and Romano, E.: A new method for noninvasive bedside determination of pulmonary blood flow, Med. & Biol. Eng. & Comp., 1980, Vol. 18, pp. 411-418) based on varying minute ventilation. Disadvantage of this method is the variation of the mean respiratory tract pressure and of the pressure at the end of expiration. Due to this variation of the respiratory tract pressure the pulmonary blood flow also varies and both the mechanical stability of the lungs and the gas exchange are impeded.
From the paper by Capek, J. M. and Roy, R J.: Noninvasive measurement of cardiac output using partial CO.sub.2 rebreathing; IEEE Transactions on Biomedical Engineering, 1988, Vol. 35, No. 9, pp. 653-661) the partial CO.sub.2 rebreathing method with change of the dead space of the apparatus is known, which is performed using a mass spectrometer and special respiratory flow sensors at the endotracheal tube and can measure the total cardiac output. The change between two different dead spaces is performed by a PC-controlled electromagnetic valve. The expiration termination partial pressure and the CO.sub.2 elimination are determined for the respiration by both dead spaces. The CO.sub.2 partial pressure at the end of expiration is converted to the arterial CO.sub.2 concentration and the total cardiac output can be calculated from the division of the CO.sub.2 elimination difference by the arterial CO.sub.2 concentration difference. A disadvantage of this method is the demand for apparatus for the measurement of the CO.sub.2 concentration in the breathed air (mass spectrometer) and of the respiratory flow at the endotracheal tube (Fleisch pneumatograph).
It is the objective of this invention to describe a clinically practicable arrangement for noninvasive determination of the effective pulmonary blood flow whereby the effective pulmonary blood flow is the cardiac output minus the intrapulmonary shunt proportion. Only that portion of the cardiac output is intended to be determined which is available for gas exchange. This arrangement requires only
REFERENCES:
patent: 5005582 (1991-04-01), Serikov et al.
patent: 5299579 (1994-04-01), Gedeon et al.d
J.M. Capek et al. : "Noninvasive Measurement of Cardiac Output Using Partial CO2 Rebreathing" IEEE Transactions on Biomedical Engineering, vol. 35, No. 9, Sep. 1, 1988, New York, U.S. pp. 653-661, XP000209300 cited in the application see p. 655, column 1, line 5--column 2, line 5.
C. C. Davis et al: "Measurements of Cardiac Output in Seriously Ill Patients Using a CO2 Rebreathing Method" Chest, vol. 73, Feb. 2, 1978, Park Ridge, IL, US, pp. 167-172, XP002056416 see p. 167, column 2, line 40--p. 169, column 2, line 34.
G.J. R. McHardy: "The Relationship Between the Differences in Pressure and Content of Carbon Dioxide in Arterial and Venous Blood" Clinical Science, vol. 32, Jan. 1, 1967, Oxford, GB, pp. 299-309, XP002056417 cited in the application, see the whole document.
Curt M. Steinhart, MD et al. : "Noninvasive determination of effective (nonshunted) pulmonary blood flow in normal and injured lungs", Crit. Care Med., 1989, vol. 17, No. 4, pp. 349-353.
A. Gedeon et al.,: "A New Method for Noninvasive Bedside Determination of Pulmonary Blood Flow", Med. & Biol. Eng. & Comp., Jul. 1980, vol. 18, pp. 411-418.
Albrecht Detlev Michael
Gama De Abreu Marcelo
Natnithithadha Navin
O'Connor Cary
Technische Universitaet Dresden
LandOfFree
Device to determine effective pulmonary blood flow does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Device to determine effective pulmonary blood flow, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Device to determine effective pulmonary blood flow will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-574985